ÂÜÀòÂÒÂ×

The Research and Development team at Thryv Therapeutics is dedicated to advancing innovative treatments for genetic disorders related to ventricular repolarization and arrhythmias. This team conducts cutting-edge research, develops new drug candidates, and oversees clinical trials to ensure the safety and efficacy of therapies. Through collaboration among scientists, clinicians, and regulatory experts, they aim to translate complex biological data into actionable therapies that improve patient outcomes.